Viewing Study NCT07297602


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2025-12-26 @ 2:35 AM
Study NCT ID: NCT07297602
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-12-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study
Sponsor: Nora Mohamed Abdelrazik
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module